Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $4.73 Million - $5.63 Million
41,382 Added 9900.0%
41,800 $5.14 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $50,996 - $60,739
418 New
418 $54,000
Q2 2021

Aug 16, 2021

SELL
$160.2 - $186.42 $16 Million - $18.6 Million
-100,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $15 Million - $17.4 Million
100,000 New
100,000 $16.4 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $8.53B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.